Identification of Skin Cancer Biopsy SitesNCT01632644
Identifying Skin Biopsy Sites
An observational study of Identification of Skin Cancer Biopsy Sites, run by Northwestern University at 1 site in United States.
Trial summary
The primary objective of this study is to investigate the patient experience during skin biopsy. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Identification of Skin Cancer Biopsy Sites
- What is being tested?
- Survey/Interview
- How many people
- 59 participants
- Where
- 1 siteUnited States
- Study dates
- Jul 2012to May 2013
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Physicians will be recruited by email obtained through directories. Patients will be those who have had biopsies at the Northwestern University Department of Dermatology.
Who may be able to join
- Age 18 and Over
- The subjects are in good health.
- The subjects have the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.
- Patients who have had one or multiple skin biopsies OR board-certified dermatologists.
Who cannot join
- Under 18 years of age.
- Subjects who are unable to understand the protocol or give informed consent.
Trial locations and contacts
1 site in 1 country.
United States1 site
Northwestern University Dermatology
Chicago, Illinois, 60611
About this study
Official title: Pilot Study of Skin Biopsy Sites: A Consensus Approach Based on Patient and Physician Interviews
The primary objective of this study is to investigate the patient experience during skin biopsy.
- Being tested
- Survey/Interview
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Survey/InterviewOther
Each group will be surveyed and interviewed.
| Study group | Role | What they receive |
|---|---|---|
| Physicians | Physicians performing skin biopsies Receives: Other: Survey/Interview | |
| Patients | Patients who have had skin biopsies Receives: Other: Survey/Interview |
What is being measured
The primary outcome is the main question the study is designed to answer.
Review of Physician and Patient Experience
Subjects will answer a combination of:
- Open-ended questions and
- Questions asking for subject to rank possible responses
Measured: Last four weeks of study
Secondary outcomes (2)
Physician's Experience with Skin Biopsy Sites
Physicians will answer a combination of:
- Open-ended questions, and
- Questions asking for subject to rank possible responses
Measured: First four weeks of study
Patient's Experience with Skin Biopsy Sites
Patients will answer a combination of:
- Open-ended questions and
- Questions asking for subject to rank possible responses
Measured: First four weeks of study
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jul 2012 (estimated)
- Study startJul 2012
- Primary completionMay 2013
- Study completionMay 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Identification of Skin Cancer Biopsy SitesStudies of the same condition, open and under way.
- More trials run by Northwestern UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 59 participants (actual)
Sponsor and investigators
- Lead sponsor
- Northwestern University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Murad Alam, Northwestern University
- Investigators
- Murad Alam, MD, Principal investigator, Northwestern University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01632644
- Sponsor's protocol ID
- STU66384
- Status last verified
- Dec 2021
- First submitted
- 27 Jun 2012
- Last updated
- 6 Dec 2021
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 6 Dec 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Pilot Study of Skin Biopsy Sites: A Consensus Approach Based on Patient and Physician Interviews
- ClinicalTrials.gov ID
- NCT01632644
- Acronym / sponsor ID
- STU66384
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 59 participants (actual)
- Lead sponsor
- Northwestern UniversityUniversity, hospital or other
- Study start
- Jul 2012
- Primary completion
- May 2013 (actual)
- Study completion
- May 2013 (actual)
- First posted
- 3 Jul 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary objective of this study is to investigate the patient experience during skin biopsy.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Physicians | – | Other: Survey/InterviewPhysicians performing skin biopsies |
| Patients | – | Other: Survey/InterviewPatients who have had skin biopsies |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Physicians will be recruited by email obtained through directories. Patients will be those who have had biopsies at the Northwestern University Department of Dermatology.
Key inclusion criteria (4 listed)
- Age 18 and Over
- The subjects are in good health.
- The subjects have the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.
- Patients who have had one or multiple skin biopsies OR board-certified dermatologists.
Key exclusion criteria (2 listed)
- Under 18 years of age.
- Subjects who are unable to understand the protocol or give informed consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Survey/InterviewEach group will be surveyed and interviewed. | Other | Patients, Physicians |
Primary outcome
Review of Physician and Patient Experience
Time frame: Last four weeks of study
Subjects will answer a combination of: 1. Open-ended questions and 2. Questions asking for subject to rank possible responses
2 secondary outcomes
Physician's Experience with Skin Biopsy Sites
Time frame: First four weeks of study
Patient's Experience with Skin Biopsy Sites
Time frame: First four weeks of study
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Dec 2021.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Murad Alam, MD principal investigator
Northwestern University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Identification of Skin Cancer Biopsy Sites, run by Northwestern University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Dec 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Review of Physician and Patient Experience (time frame: Last four weeks of study). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Dec 2021; AzTrials last refreshed its copy on 31 Oct 2026.